Sanderson, MR; Laponogov, I; Pan, X; Veselkov, DA; Crevel, IM-T; Selvarajah, J; Branstrom, A; Cirz, R; Moser, HE; Fisher, LM
(2017)
Studies of prokaryotic Type II topoisomerase drug inhibition.
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 73 (a2).
C633-C633.
ISSN 2053-2733
https://doi.org/10.1107/S2053273317089409
SGUL Authors: Fisher, Larry Mark Pan, Xiao Su
|
PDF
Published Version
Available under License ["licenses_description_publisher" not defined]. Download (48kB) | Preview |
| Item Type: | Article | ||||
|---|---|---|---|---|---|
| Additional Information: | Acta Cryst. (2017). A73, C633 https://doi.org/10.1107/S2053273317089409 | ||||
| Keywords: | drug development, topoisomerase II, bacterial enzyme targeting | ||||
| SGUL Research Institute / Research Centre: | Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) | ||||
| Journal or Publication Title: | ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES | ||||
| ISSN: | 2053-2733 | ||||
| Dates: |
|
||||
| Publisher License: | Publisher's own licence | ||||
| Web of Science ID: | WOS:000481522000632 | ||||
| URI: | https://openaccess.sgul.ac.uk/id/eprint/111159 | ||||
| Publisher's version: | https://doi.org/10.1107/S2053273317089409 |
Statistics
Item downloaded times since 09 Sep 2019.
Actions (login required)
 |
Edit Item |